COMPARISON OF THE MEDICATION ADHERENCE OF PATIENTS TREATED WITH TELMISARTAN/HYDROCHLOROTHIAZIDE OR TELMISARTAN/AMLODIPINE FIXED DOSE COMBINATION (FDC) VERSUS DOUBLE-PILL COMBINATION THERAPY IN REAL-WORLD JAPANESE THERAPEUTIC PRACTICE: